Help Us Investigate Medical Care for Gunshot Wounds
KFF Health News and The Trace are teaming up to take a deep look at…
Help Us Investigate Medical Care for Gunshot Wounds
KFF Health News and The Trace are teaming up to take a deep look at how insurance status affects treatment for gunshot wounds. We’re looking for survivors, their friends and family, or family members of people who suffered complications or died from gunshot wounds after leaving the hospital. We want to hear about medical treatment,…
Building Supply Chain Resilience in the Face of Tariffs and Disruption
The reality is that tariffs are only the latest disruption in a long line of constant volatility throughout the healthcare supply chain. Here are five ways to build resilience amid tariffs and before the next disruption strikes. The post Building Supply Chain Resilience in the Face of Tariffs and Disruption appeared first on MedCity News.
Testosterone Therapy in North Carolina: Top-Rated Clinics and Specialists
[Sponsored] “TRT is an understated treatment option for many, as it can help with fatigue, hot flashes and myriad other health factors. Dispel some of the most confusing aspects of testosterone therapy…” The post Testosterone Therapy in North Carolina: Top-Rated Clinics and Specialists appeared first on MedCity News.
Privacy Rules Are Tightening, Again. Here’s How Your Healthcare Marketing Can Embrace Compliance to Thrive
How can healthcare providers contend with a regulatory environment that has never been more fragmented? Here are three lessons on why privacy is your competitive advantage. The post Privacy Rules Are Tightening, Again. Here’s How Your Healthcare Marketing Can Embrace Compliance to Thrive appeared first on MedCity News.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
[Sponsored] In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation. The post The Power of One: Redefining Healthcare with an AI-Driven Unified Platform appeared first on MedCity News.
A Small Texas Think Tank Cultivated Covid Dissidents. Now They’re Running US Health Policy.
Martin Kulldorff, chair of the Trump administration’s reconstituted CDC vaccine panel, made a shocking — and misleading — statement as the group met in September. Referring to a clinical trial, Kulldorff, a biostatistician and former professor at Harvard Medical School, said eight babies born to women who received Pfizer’s covid vaccine while pregnant had birth…
A Hidden Health Crisis Following Natural Disasters: Mold Growth in Homes
TALLAHASSEE, Fla. — After returning from what felt like the best internship of her life, Danae Daniels was excited to unwind and settle into a new semester at Florida Agricultural and Mechanical University. But when she opened the door to her off-campus apartment, she was met with an overwhelming smell — and a devastating reality….
With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis
Arrowhead Pharmaceuticals’ RNAi drug plozasiran, brand name Redemplo, is now the second FDA-approved therapy for familial chylomicronemia syndrome, an inherited lipid disorder. Beyond its claims of safety and dosing advantages, Arrowhead set a dramatically lower price for its first commercial product, which will compete against an Ionis Pharmaceuticals drug. The post With FDA Approval for…
Pyx Health Introduces Platform to Support Those Affected by OBBBA
Pyx Health launched an AI-driven platform to help members navigate care, meet new Medicaid and SNAP requirements and address social needs like food insecurity. The post Pyx Health Introduces Platform to Support Those Affected by OBBBA appeared first on MedCity News.
Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins
This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the drug widely being considered a major advance, early evidence suggests that insurance coverage and benefit design decisions may create barriers to access.
